FDA Approves Gene Editing Therapy to Alleviate Human Illness | EWTN News Nightly
- Preacher
- Mother Angelica
- Tradition
- Roman Catholic
- Published
- Length
- 3:46
About this sermon
Late last week, the Food and Drug Administration approved the first-ever gene editing therapy to alleviate human illness. The procedure will treat those 12 and older suffering from sickle-cell disease, what the FDA calls a "rare, debilitating and life-threatening blood disorder with significant unmet need." In the trial run, 96.7% of those treated saw their pain resolved for at least 18 months, but despite the positive results, there are 2 main concerns, the expensive price-tag and the high likelihood for infertility following the procedure. President of the National Catholic Bioethics Center, Dr. Joseph Meaney, joins to share his thoughts on this groundbreaking treatment. From a Catholic, ethical perspective, Dr. Meaney tells us what the Church teaches about gene editing therapies and how the Church would look at this particular therapy. Treatment has a potentially high risk of infertility. Dr. Meany talks to us about that, as it is obviously a big concern especially from a Catholic ethical perspective. The cost is also a big concern, even with health insurance it comes with a hefty price. ------------ EWTN News Nightly provides the latest news and analysis from a Catholic perspective. Join host Tracy Sabol, our Capitol Hill, White House and Rome Correspondents, as well as many other diverse guests daily, to get the latest from the U.S. and the Vatican on topics regarding our Catholic faith and interests. ------------- EWTN News Nightly airs on EWTN weekdays at 6pm & 9pm ET. ------------ Don't miss an episode of EWTN New Nightly. Get updates here: https://www.ewtn.com/tv/shows/ewtn-news-nightly ------------- Sign up today to receive the EWTN News Nightly newsletter: https://www.ewtn.com/enn ------------- Follow EWTN News Nightly on Social Media: Facebook: https://www.facebook.com/ewtnnewsnightly Twitter: https://twitter.com/EWTNNewsNightly Instagram: https://www.instagram.com/ewtnnewsnightly/ ------------- Subscribe to EWTN YouTube channel here: https://www.youtube.com/user/EWTN ------------- You can support the EWTN News mission: https://bit.ly/3qDR1qf
Inspired by this message? Prepare your own sermon with SermonAI.
Try SermonAI free for 7 days





